Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

MYSZ vs XERS vs LNTH vs FIGS vs SHOP

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
MYSZ
My Size, Inc.

Software - Application

TechnologyNASDAQ • IL
Market Cap$528K
5Y Perf.-99.8%
XERS
Xeris Biopharma Holdings, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$1.13B
5Y Perf.+109.3%
LNTH
Lantheus Holdings, Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • US
Market Cap$6.06B
5Y Perf.+283.8%
FIGS
FIGS, Inc.

Apparel - Manufacturers

Consumer CyclicalNYSE • US
Market Cap$1.94B
5Y Perf.-65.9%
SHOP
Shopify Inc.

Software - Application

TechnologyNASDAQ • CA
Market Cap$143.40B
5Y Perf.-11.1%

MYSZ vs XERS vs LNTH vs FIGS vs SHOP — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
MYSZ logoMYSZ
XERS logoXERS
LNTH logoLNTH
FIGS logoFIGS
SHOP logoSHOP
IndustrySoftware - ApplicationBiotechnologyDrug Manufacturers - Specialty & GenericApparel - ManufacturersSoftware - Application
Market Cap$528K$1.13B$6.06B$1.94B$143.40B
Revenue (TTM)$8M$315M$1.55B$666M$12.37B
Net Income (TTM)$-4M$12M$279M$41M$1.33B
Gross Margin38.7%59.4%60.5%66.6%48.0%
Operating Margin-49.1%11.4%18.8%6.4%13.3%
Forward P/E50.8x17.7x47.5x60.1x
Total Debt$276K$38M$738K$60M$188M
Cash & Equiv.$5M$111M$359M$82M$1.53B

MYSZ vs XERS vs LNTH vs FIGS vs SHOPLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

MYSZ
XERS
LNTH
FIGS
SHOP
StockMay 21May 26Return
My Size, Inc. (MYSZ)1000.2-99.8%
Xeris Biopharma Hol… (XERS)100209.3+109.3%
Lantheus Holdings, … (LNTH)100383.8+283.8%
FIGS, Inc. (FIGS)10034.1-65.9%
Shopify Inc. (SHOP)10088.9-11.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: MYSZ vs XERS vs LNTH vs FIGS vs SHOP

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: LNTH leads in 4 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Xeris Biopharma Holdings, Inc. is the stronger pick specifically for growth and revenue expansion. FIGS also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
MYSZ
My Size, Inc.
The Technology Pick

MYSZ lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: technology exposure
XERS
Xeris Biopharma Holdings, Inc.
The Growth Play

XERS is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 43.7%, EPS growth 100.9%, 3Y rev CAGR 38.3%
  • 43.7% revenue growth vs LNTH's 0.5%
Best for: growth exposure
LNTH
Lantheus Holdings, Inc.
The Income Pick

LNTH carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 0 yrs, beta 0.45
  • 42.9% 10Y total return vs SHOP's 40.8%
  • Lower volatility, beta 0.45, Low D/E 0.1%, current ratio 2.70x
  • Beta 0.45, current ratio 2.70x
Best for: income & stability and long-term compounding
FIGS
FIGS, Inc.
The Momentum Pick

FIGS ranks third and is worth considering specifically for momentum.

  • +130.3% vs MYSZ's -54.7%
Best for: momentum
SHOP
Shopify Inc.
The Growth Angle

Among these 5 stocks, SHOP doesn't own a clear edge in any measured category.

Best for: technology exposure
See the full category breakdown
CategoryWinnerWhy
GrowthXERS logoXERS43.7% revenue growth vs LNTH's 0.5%
ValueLNTH logoLNTHLower P/E (17.7x vs 60.1x)
Quality / MarginsLNTH logoLNTH18.0% margin vs MYSZ's -47.4%
Stability / SafetyLNTH logoLNTHBeta 0.45 vs SHOP's 2.49, lower leverage
DividendsTieNone of these 5 stocks pay a meaningful dividend
Momentum (1Y)FIGS logoFIGS+130.3% vs MYSZ's -54.7%
Efficiency (ROA)LNTH logoLNTH12.4% ROA vs MYSZ's -30.5%, ROIC 30.6% vs -106.7%

MYSZ vs XERS vs LNTH vs FIGS vs SHOP — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

MYSZMy Size, Inc.
FY 2024
Fashion and Equipment ECommerce Platform
91.2%$8M
Saas Solutions
8.8%$729,000
XERSXeris Biopharma Holdings, Inc.
FY 2025
Product
85.1%$283M
Keveyis
14.3%$48M
Product, Other
0.6%$2M
LNTHLantheus Holdings, Inc.
FY 2025
Product
33.4%$1.5B
Radiopharmaceutical Oncology
21.9%$989M
PYLARIFY
21.9%$989M
Total Precision Diagnostics
10.9%$493M
DEFINITY
7.3%$330M
Techne Lite
1.9%$87M
Strategic Partnerships And Other
1.3%$59M
Other (2)
1.3%$59M
FIGSFIGS, Inc.
FY 2025
Scrubwear
80.6%$509M
Non-scrubwear/Lifestyle
19.4%$122M
SHOPShopify Inc.
FY 2025
Service
76.2%$8.8B
Subscription and Circulation
23.8%$2.8B

MYSZ vs XERS vs LNTH vs FIGS vs SHOP — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLLNTHLAGGINGSHOP

Income & Cash Flow (Last 12 Months)

LNTH leads this category, winning 3 of 6 comparable metrics.

SHOP is the larger business by revenue, generating $12.4B annually — 1646.2x MYSZ's $8M. LNTH is the more profitable business, keeping 18.0% of every revenue dollar as net income compared to MYSZ's -47.4%. On growth, MYSZ holds the edge at +39.9% YoY revenue growth, suggesting stronger near-term business momentum.

MetricMYSZ logoMYSZMy Size, Inc.XERS logoXERSXeris Biopharma H…LNTH logoLNTHLantheus Holdings…FIGS logoFIGSFIGS, Inc.SHOP logoSHOPShopify Inc.
RevenueTrailing 12 months$8M$315M$1.5B$666M$12.4B
EBITDAEarnings before interest/tax-$3M$45M$347M$50M$1.7B
Net IncomeAfter-tax profit-$4M$12M$279M$41M$1.3B
Free Cash FlowCash after capex-$4M$38M$372M$39M$2.1B
Gross MarginGross profit ÷ Revenue+38.7%+59.4%+60.5%+66.6%+48.0%
Operating MarginEBIT ÷ Revenue-49.1%+11.4%+18.8%+6.4%+13.3%
Net MarginNet income ÷ Revenue-47.4%+3.8%+18.0%+6.1%+10.8%
FCF MarginFCF ÷ Revenue-46.9%+12.0%+24.0%+5.9%+17.2%
Rev. Growth (YoY)Latest quarter vs prior year+39.9%+38.3%+1.2%+28.0%+34.3%
EPS Growth (YoY)Latest quarter vs prior year+68.0%+116.5%+76.5%+15.1%
LNTH leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — MYSZ and LNTH each lead in 3 of 6 comparable metrics.

At 27.3x trailing earnings, LNTH trades at a 99% valuation discount to XERS's 2040.6x P/E. On an enterprise value basis, LNTH's 15.0x EV/EBITDA is more attractive than SHOP's 94.8x.

MetricMYSZ logoMYSZMy Size, Inc.XERS logoXERSXeris Biopharma H…LNTH logoLNTHLantheus Holdings…FIGS logoFIGSFIGS, Inc.SHOP logoSHOPShopify Inc.
Market CapShares × price$528,240$1.1B$6.1B$1.9B$143.4B
Enterprise ValueMkt cap + debt − cash-$4M$1.1B$5.7B$1.9B$142.1B
Trailing P/EPrice ÷ TTM EPS-0.13x2040.63x27.29x61.21x117.56x
Forward P/EPrice ÷ next-FY EPS est.50.78x17.70x47.47x60.15x
PEG RatioP/E ÷ EPS growth rate4.01x
EV / EBITDAEnterprise value multiple28.41x14.96x40.71x94.76x
Price / SalesMarket cap ÷ Revenue0.06x3.86x3.93x3.08x12.41x
Price / BookPrice ÷ Book value/share0.08x82.40x5.84x4.77x10.70x
Price / FCFMarket cap ÷ FCF40.31x17.11x36.65x71.45x
Evenly matched — MYSZ and LNTH each lead in 3 of 6 comparable metrics.

Profitability & Efficiency

LNTH leads this category, winning 4 of 9 comparable metrics.

XERS delivers a 7.3% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-49 for MYSZ. LNTH carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to XERS's 2.76x. On the Piotroski fundamental quality scale (0–9), XERS scores 7/9 vs LNTH's 5/9, reflecting strong financial health.

MetricMYSZ logoMYSZMy Size, Inc.XERS logoXERSXeris Biopharma H…LNTH logoLNTHLantheus Holdings…FIGS logoFIGSFIGS, Inc.SHOP logoSHOPShopify Inc.
ROE (TTM)Return on equity-48.8%+7.3%+24.3%+9.7%+10.5%
ROA (TTM)Return on assets-30.5%+3.2%+12.4%+7.4%+9.0%
ROICReturn on invested capital-106.7%+33.8%+30.6%+7.5%+9.4%
ROCEReturn on capital employed-64.8%+10.0%+17.1%+8.4%+11.4%
Piotroski ScoreFundamental quality 0–967576
Debt / EquityFinancial leverage0.04x2.76x0.00x0.14x0.01x
Net DebtTotal debt minus cash-$5M-$73M-$358M-$22M-$1.3B
Cash & Equiv.Liquid assets$5M$111M$359M$82M$1.5B
Total DebtShort + long-term debt$276,000$38M$738,000$60M$188M
Interest CoverageEBIT ÷ Interest expense-123.93x1.12x15.83x
LNTH leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

LNTH leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in LNTH five years ago would be worth $43,814 today (with dividends reinvested), compared to $25 for MYSZ. Over the past 12 months, FIGS leads with a +130.3% total return vs MYSZ's -54.7%. The 3-year compound annual growth rate (CAGR) favors XERS at 39.6% vs MYSZ's -60.7% — a key indicator of consistent wealth creation.

MetricMYSZ logoMYSZMy Size, Inc.XERS logoXERSXeris Biopharma H…LNTH logoLNTHLantheus Holdings…FIGS logoFIGSFIGS, Inc.SHOP logoSHOPShopify Inc.
YTD ReturnYear-to-date-28.5%-11.2%+38.3%+2.1%-29.7%
1-Year ReturnPast 12 months-54.7%+26.6%+15.7%+130.3%+17.6%
3-Year ReturnCumulative with dividends-93.9%+172.1%-1.9%+45.4%+71.6%
5-Year ReturnCumulative with dividends-99.8%+100.3%+338.1%-61.3%+2.3%
10-Year ReturnCumulative with dividends-100.0%-67.7%+4289.6%-61.3%+4076.3%
CAGR (3Y)Annualised 3-year return-60.7%+39.6%-0.6%+13.3%+19.7%
LNTH leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

LNTH leads this category, winning 2 of 2 comparable metrics.

LNTH is the less volatile stock with a 0.45 beta — it tends to amplify market swings less than SHOP's 2.49 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LNTH currently trades 98.1% from its 52-week high vs MYSZ's 35.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricMYSZ logoMYSZMy Size, Inc.XERS logoXERSXeris Biopharma H…LNTH logoLNTHLantheus Holdings…FIGS logoFIGSFIGS, Inc.SHOP logoSHOPShopify Inc.
Beta (5Y)Sensitivity to S&P 5001.12x0.87x0.45x0.97x2.49x
52-Week HighHighest price in past year$1.65$10.08$94.86$17.48$182.19
52-Week LowLowest price in past year$0.50$4.30$47.25$4.25$88.14
% of 52W HighCurrent price vs 52-week peak+35.2%+64.8%+98.1%+66.5%+60.7%
RSI (14)Momentum oscillator 0–10039.764.469.953.141.7
Avg Volume (50D)Average daily shares traded45K1.9M872K3.8M8.7M
LNTH leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: XERS as "Buy", LNTH as "Buy", FIGS as "Buy", SHOP as "Buy". Consensus price targets imply 41.9% upside for SHOP (target: $157) vs 6.7% for LNTH (target: $99).

MetricMYSZ logoMYSZMy Size, Inc.XERS logoXERSXeris Biopharma H…LNTH logoLNTHLantheus Holdings…FIGS logoFIGSFIGS, Inc.SHOP logoSHOPShopify Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$9.00$99.25$12.92$156.79
# AnalystsCovering analysts10171563
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.0%+5.0%+0.1%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

LNTH leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 1 category is tied.

Best OverallLantheus Holdings, Inc. (LNTH)Leads 4 of 6 categories
Loading custom metrics...

MYSZ vs XERS vs LNTH vs FIGS vs SHOP: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is MYSZ or XERS or LNTH or FIGS or SHOP a better buy right now?

For growth investors, Xeris Biopharma Holdings, Inc.

(XERS) is the stronger pick with 43. 7% revenue growth year-over-year, versus 0. 5% for Lantheus Holdings, Inc. (LNTH). Lantheus Holdings, Inc. (LNTH) offers the better valuation at 27. 3x trailing P/E (17. 7x forward), making it the more compelling value choice. Analysts rate Xeris Biopharma Holdings, Inc. (XERS) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — MYSZ or XERS or LNTH or FIGS or SHOP?

On trailing P/E, Lantheus Holdings, Inc.

(LNTH) is the cheapest at 27. 3x versus Xeris Biopharma Holdings, Inc. at 2040. 6x. On forward P/E, Lantheus Holdings, Inc. is actually cheaper at 17. 7x.

03

Which is the better long-term investment — MYSZ or XERS or LNTH or FIGS or SHOP?

Over the past 5 years, Lantheus Holdings, Inc.

(LNTH) delivered a total return of +338. 1%, compared to -99. 8% for My Size, Inc. (MYSZ). Over 10 years, the gap is even starker: LNTH returned +42. 9% versus MYSZ's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — MYSZ or XERS or LNTH or FIGS or SHOP?

By beta (market sensitivity over 5 years), Lantheus Holdings, Inc.

(LNTH) is the lower-risk stock at 0. 45β versus Shopify Inc. 's 2. 49β — meaning SHOP is approximately 447% more volatile than LNTH relative to the S&P 500. On balance sheet safety, Lantheus Holdings, Inc. (LNTH) carries a lower debt/equity ratio of 0% versus 3% for Xeris Biopharma Holdings, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — MYSZ or XERS or LNTH or FIGS or SHOP?

By revenue growth (latest reported year), Xeris Biopharma Holdings, Inc.

(XERS) is pulling ahead at 43. 7% versus 0. 5% for Lantheus Holdings, Inc. (LNTH). On earnings-per-share growth, the picture is similar: FIGS, Inc. grew EPS 1158% year-over-year, compared to -39. 4% for Shopify Inc.. Over a 3-year CAGR, MYSZ leads at 298. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — MYSZ or XERS or LNTH or FIGS or SHOP?

Lantheus Holdings, Inc.

(LNTH) is the more profitable company, earning 15. 2% net margin versus -48. 4% for My Size, Inc. — meaning it keeps 15. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LNTH leads at 20. 2% versus -47. 8% for MYSZ. At the gross margin level — before operating expenses — XERS leads at 81. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is MYSZ or XERS or LNTH or FIGS or SHOP more undervalued right now?

On forward earnings alone, Lantheus Holdings, Inc.

(LNTH) trades at 17. 7x forward P/E versus 60. 1x for Shopify Inc. — 42. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SHOP: 41. 9% to $156. 79.

08

Which pays a better dividend — MYSZ or XERS or LNTH or FIGS or SHOP?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is MYSZ or XERS or LNTH or FIGS or SHOP better for a retirement portfolio?

For long-horizon retirement investors, Lantheus Holdings, Inc.

(LNTH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 45)). Shopify Inc. (SHOP) carries a higher beta of 2. 49 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LNTH: +42. 9%, SHOP: +40. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between MYSZ and XERS and LNTH and FIGS and SHOP?

These companies operate in different sectors (MYSZ (Technology) and XERS (Healthcare) and LNTH (Healthcare) and FIGS (Consumer Cyclical) and SHOP (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MYSZ is a small-cap high-growth stock; XERS is a small-cap high-growth stock; LNTH is a small-cap quality compounder stock; FIGS is a small-cap quality compounder stock; SHOP is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

MYSZ

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 19%
  • Gross Margin > 23%
Run This Screen
Stocks Like

XERS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 19%
  • Gross Margin > 35%
Run This Screen
Stocks Like

LNTH

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 10%
Run This Screen
Stocks Like

FIGS

High-Growth Disruptor

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

SHOP

High-Growth Compounder

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 17%
  • Net Margin > 6%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform MYSZ and XERS and LNTH and FIGS and SHOP on the metrics below

Revenue Growth>
%
(MYSZ: 39.9% · XERS: 38.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.